Pharmaceuticals

Slide2-min36.JPG

FMS-like Tyrosine Kinase 3 Inhibitors Market Size, Share & Trends Analysis Report By Drug Type (Mideastern, Gilbertian, Sorafenib), By Therapies (Type 1 FMS, Type 2 FMS), By Region, And By Segment Forecasts, 2024-2031

The FMS-like Tyrosine Kinase 3 Inhibitors Market Size is valued at 495.07 Million in 2023 and is predicted to reach 1455.43 Million by the year 2031 at a 14.74 % CAGR during the forecast period for 2024-2031.  The effects of inhibit...

View Sample PDF

Slide2-min_(1)41.JPG

Global Multiple Cancer Monoclonal Antibodies Market Size, Share & Trends Analysis Report By Product Type (Cetuximab, Nivolumab, Atezolizumab, Ramucirumab, Pembrolizumab and Others), By Indication Type, By Region, And Segment Forecasts, 2024-2031

The Global Multiple Cancer Monoclonal Antibodies Market Size is valued at 67.21 billion in 2023 and is predicted to reach 154.24 billion by the year 2031 at a 11.19% CAGR during the forecast period for 2024-2031. Cancer monoclonal antibodies ...

View Sample PDF

Global_Bioelectric_Medicine_Market.jpg

Bioelectric Medicine Market Size, Share & Trends Analysis Report By Product Type (Competitive Benchmarking, Implantable Bioelectric Medicine, Non-Implantable Bioelectric Medicine), By Region, And By Segment Forecasts, 2024-2031

The Bioelectric Medicine Market Size is valued at 24.08 Billion in 2023 and is predicted to reach 43.03 Billion by the year 2031 at a 7.72 % CAGR during the forecast period for 2024-2031. Bioelectric medicine is a branch of medicine that...

View Sample PDF

Small_Molecule_Immunomodulators_Market.JPG

Small Molecule Immunomodulators Market Size, Share & Trends Analysis Report By Product (Disposable, Reusable), By Application (Colorectal, Thoracic, Orthopedic, Ophthalmology, Neurosurgery, Cardiac Surgery, Gynecology, Others), By End User (Hospitals, Ambulatory Surgical Centers, Clinics, Others), By Region, And By Segment Forecasts, 2024-2031.

Small Molecule Immunomodulators Market Size is valued at USD 170.74 Bn in 2023 and is predicted to reach USD 270.77 Bn by the year 2031 at a 6.07% CAGR during the forecast period for 2024-2031. Small molecule immunomodulators are compounds with lo...

View Sample PDF

Categories